Skip to main content

Cormorant Asset Management, LP

Source: SEC Form 13F · as of Mar 2026

Cormorant Asset Management, LP holds 29 biotech & pharma companies tracked by BioSniper, totaling $851.8M in value as of Mar 2026 (SEC Form 13F).

Companies held

29

Total value held

$851.8M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Edgewise Therapeutics, Inc. (EWTX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
EWTXEdgewise Therapeutics, Inc.3,260,000$102.7M
ERASErasca, Inc.5,800,000$93.8M
ABVXAbivax SA760,000$84.6M
DNTHDianthus Therapeutics, Inc. /DE/950,000$79.7M
BBIOBridgeBio Pharma, Inc.850,000$63.1M
CNTACentessa Pharmaceuticals plc1,050,000$41.7M
DMRADamora Therapeutics, Inc.1,525,000$39.5M
MBXMBX Biosciences, Inc.1,120,000$33.4M
INSMINSMED Inc190,000$31.1M
NAMSNEWAMSTERDAM PHARMA CO N.V.950,000$30.4M
TNGXTango Therapeutics, Inc.1,425,000$29.8M
PHVSPharvaris N.V.1,000,000$28.3M
ORKAOruka Therapeutics, Inc.533,340$26.2M
MAZEMaze Therapeutics, Inc.750,000$22.4M
ROIVRoivant Sciences Ltd.750,000$20.8M
TERNTerns Pharmaceuticals, Inc.300,000$15.8M
TARSTarsus Pharmaceuticals, Inc.225,000$15.8M
BHVNBiohaven Ltd.1,760,000$14.9M
ARQTArcutis Biotherapeutics, Inc.450,000$10.6M
CRNXCrinetics Pharmaceuticals, Inc.250,000$9.1M
ZURAZura Bio Ltd1,450,000$8.6M
AXSMAxsome Therapeutics, Inc.50,000$8.5M
GPCRStructure Therapeutics Inc.175,000$8.4M
COGTCogent Biosciences, Inc.200,000$7.7M
GLUEMonte Rosa Therapeutics, Inc.400,000$6.6M
ARWRARROWHEAD PHARMACEUTICALS, INC.100,000$6.3M
PCVXVaxcyte, Inc.100,000$5.8M
AMLXAmylyx Pharmaceuticals, Inc.350,000$4.9M
CNTXContext Therapeutics Inc.529,550$1.4M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.